Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
F. Zeka, A. Van Goethem, K. Vanderheyden, F. Demuynck, T. Lammens, A. Decock, H. H. Helsmoortel, J. Vermeulen, R. Noguera, A. P. Berbegall, V. Combaret, G. Schleiermacher, G. Laureys, A. Schramm, J. H. Schulte, S. Rahmann, J. Bienertova Vasku, P. Mazanek, M. Jeison, S. Ash, M. D. Hogarty, M. Moreno-Smith, E. Barbieri, J. Shohet, F. Berthold, , J. Vandesompele
Abstract
In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of non-invasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743 miRNAs were screened in two independent cohorts of 131 and 54 patients. Evaluation of serum miRNA variance in a model testing for tumor stage, MYCN status, age at diagnosis and overall survival, revealed tumor stage as the most significant factor impacting miRNA abundance in neuroblastoma serum. Differential expression analysis between patients with metastatic and localized disease revealed 9 miRNAs strongly associated with metastatic stage 4 disease in both patient cohorts. Increasing levels of these miRNAs were also observed in serum from xenografted mice bearing human neuroblastoma tumors. Moreover, murine serum miRNA levels were strongly associated with tumor volume, suggesting this miRNA signature may be applied to monitor disease burden.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R. Vayani, Maria E. Kaufman, … Mark A. Applebaum·Pediatric Blood & CancerPeer-reviewed·Oct 20, 2023
- Machine learning based identification of candidate miRNA biomarkers for micro-invasive breast cancer diagnosis
Jayanta Kumar Pal, Bhadresh R. Rami·bioRxiv·Aug 16, 2024
- Investigating miRNA signatures in metastatic breast cancer: An in silico analysis.
- Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of Triple Negative Breast Cancer
Ananya Choudhary, Satish S. Poojary, … Bhudev C. Das·BMC CancerPeer-reviewed·Jan 13, 2026
- A cross-cancer metastasis signature in the microRNA-mRNA axis of paired tissue samples
S. C. Lee, A. Quinn, … T. P. Quinn·bioRxiv·Dec 2, 2018
- A microRNA Signature of Metastatic Colorectal Cancer
E. Hoye, B. Fromm, … K. Flatmark·bioRxiv·Jun 1, 2020